论文部分内容阅读
国家药品监督管理局正加紧对尚未纳入国家药品标准管理的部分地方中成药品种进行整顿,中成药地方标准升国家标准工作将于2002年全部完成。 到目前为止,国家药监局共受理申请升为国家标准的地方标准中成药(中成药、原料药)5 007个;受理单品种数2 554个;受理中成药品种数4 554
The State Drug Administration is stepping up efforts to rectify the varieties of proprietary Chinese medicines that have not yet been incorporated into the management of the national drug standards. The local standards for Chinese patent medicines will be completed in 2002. So far, the SFDA has accepted a total of 5,007 local patents for Chinese medicines (Chinese patent medicines and APIs) that have been applied for promotion to national standards; the number of admissible single-products has reached 2,554; and the number of Chinese patent medicines accepted has been 4,554.